Skip to main content

Table 3 PE occurrence in the LDA group

From: Aspirin 75 mg to prevent preeclampsia in high-risk pregnancies: a retrospective real-world study in China

 

Total

PE (n = 12)

non-PE (n = 103)

P

Onset of LDA

   

0.0239

 ≤ 16 gestational weeks

64

3 (4.69%)

61 (95.31%)

 

 > 16 gestational weeks

51

9 (17.65%)

42 (82.35%)

 

ACOG Risk factor

 Age (years)

   

0.3811

  ≥ 35

42

3 (7.14%)

39 (92.86%)

 

  < 35

73

9 (12.33%)

64 (87.67%)

 

 BMI (kg/m2)

   

0.4640

  ≥ 30

26

4 (15.38%)

22 (84.62%)

 

  < 30

89

8 (8.99%)

81 (91.01%)

 

 History of PE

   

0.7163

  Yes

3

0 (0.00%)

3 (100.00%)

 

  No

112

12 (10.71%)

100 (89.29%)

 

 Family history of PE

   

0.6395

  Yes

4

0 (0.00%)

4 (100.00%)

 

  No

111

12 (10.81%)

99 (89.19%)

 

 Pre-existing diabetes

   

0.2328

  Y es

11

2 (18.18%)

9 (81.82%)

 

  No

104

10 (9.62%)

94 (90.38%)

 

 Chronic hypertension

   

 < 0.0001

  Yes

7

4 (57.14%)

3 (42.86%)

 

  No

108

8 (7.41%)

100 (92.59%)

 

 Nulliparous

   

0.4803

  Yes

56

7 (12.50%)

49 (87.50%)

 

  No

59

5 (8.47%)

54 (91.53%)

 

 Multiple pregnancy

   

0.7123

  Yes

24

3 (12.50%)

21 (87.50%)

 

  No

91

9 (9.89%)

82 (90.11%)

 
  1. PE preeclampsia, LDA low-dose aspirin, ACOG American college of obstetricians and gynecologists, BMI body mass index.
  2. P-values <0.05 are emphasized on bold font.